Neoantigen Quality Predicts Immune Response, Survival

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nb2017-165
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Response to Steroids Predicts Response to Rituximab in Pediatric Chronic Immune Thrombocytopenia.

Blood
BiochemistryImmunologyCell BiologyHematology
2010English

Response to Steroids Predicts Response to Rituximab in Pediatric Chronic Immune Thrombocytopenia

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2011English

Survival Correlation of Immune Response in Human Cancers

Oncotarget
Oncology
2019English

Radiographic Response to Locoregional Therapy in Hepatocellular Carcinoma Predicts Patient Survival Times

2011English

Peripheral Immune Cell Gene Expression Predicts Survival of Patients With Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2012English

Thrombopoietin Level Predicts Response to Treatment With Eltrombopag and Romiplostim in Immune Thrombocytopenia

American Journal of Hematology
Hematology
2018English

CXCR3 From Chemokine Receptor Family Correlates With Immune Infiltration and Predicts Poor Survival in Osteosarcoma

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2019English

Poor Baseline Immune Function Predicts an Incomplete Immune Response to Combination Antiretroviral Treatment Despite Sustained Viral Suppression

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2009English

Cervical Cancer Neoantigen Landscape and Immune Activity Is Associated With Human Papillomavirus Master Regulators

Frontiers in Immunology
AllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy